Point72 Hong Kong’s GenMark Diagnostics, Inc GNMK Stock Holding History

Point72 Hong Kong’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-806	Closed	-$11K	–	2172
2020 Q3	$11K	Sell	806 -3,617	-82%	-$55.3K	﹤0.01%	985
2020 Q2	$65K	Buy	+4,423	New	+$44.9K	0.01%	704
2020 Q1	–	Sell	-811	Closed	-$4K	–	1520
2019 Q4	$4K	Buy	+811	New	+$4.47K	﹤0.01%	1060
2019 Q3	–	Sell	-111	Closed	-$1K	–	1490
2019 Q2	$1K	Buy	+111	New	+$782	﹤0.01%	1078
2017 Q3	–	Sell	-730	Closed	-$9K	–	1150
2017 Q2	$9K	Buy	+730	New	+$9.33K	0.01%	491

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Hong Kong's GNMK Position: Q4 2020 in Review

Point72 Hong Kong sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2020, closing a stake of 806 shares — an estimated $11K sold.

Point72 Hong Kong first reported a position in GNMK in Q2 2017 and held it in 5 quarters. The position peaked at $65K in Q2 2020. 151 funds tracked by Wall St. Rank hold GNMK as of Q4 2020.

Point72 Hong Kong reported no remaining GenMark Diagnostics, Inc position as of Q4 2020 after selling out during the quarter.
Point72 Hong Kong sold 806 GenMark Diagnostics, Inc shares in Q4 2020, an estimated $11K.
Point72 Hong Kong first reported a position in GenMark Diagnostics, Inc in Q2 2017 and held it in 5 quarters.
Point72 Hong Kong's GenMark Diagnostics, Inc position peaked at $65K in Q2 2020.
151 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2020.

Based on Point72 Hong Kong's 13F filing for Q4 2020, filed 16 Feb 2021.